Anna Melissa Lo, MD
Endocrinology, Diabetes & Metabolism · Honolulu, HINPI 1417308685
Payments from drug & device makers
Across 602 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Novo Nordisk$2K
- Lilly USA, LLC$2K
- Dexcom, Inc.$1K
- Bayer$1K
- Abbott$1K
- plus $5K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 87 | $1,803 |
| Novo Nordisk | 79 | $1,629 |
| Lilly USA, LLC | 69 | $1,517 |
| Dexcom, Inc. | 56 | $1,305 |
| Bayer | 59 | $1,143 |
| Abbott | 59 | $1,072 |
| AstraZeneca(2 entities) | 26 | $759 |
| Corcept Therapeutics | 24 | $754 |
| Boehringer Ingelheim | 24 | $619 |
| Amarin Pharma, Inc. | 32 | $402 |
| Mannkind Corporation | 11 | $367 |
| Medtronic | 10 | $340 |
| Insulet Corporation | 14 | $313 |
| Sanofi-aventis U.S. LLC | 16 | $258 |
| Xeris Pharmaceuticals, Inc. | 7 | $151 |
| Tandem Diabetes Care, Inc. | 5 | $99 |
| Esperion Therapeutics, Inc. | 4 | $82 |
| Novartis | 4 | $72 |
| Merck | 3 | $71 |
| Radius Health, Inc. | 3 | $71 |
| Chiesi USA, Inc. | 2 | $49 |
| Neurocrine Biosciences, Inc. | 1 | $32 |
| AbbVie | 1 | $27 |
| Lundbeck LLC | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| LEO Pharma Inc. | 1 | $17 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Johnson & Johnson | 1 | $12 |
How this compares
$13,046 in reported general payments places this provider in the 80th percentile of 22 endocrinology, diabetes & metabolism providers in Hawaii.
See all endocrinology, diabetes & metabolism providers in Hawaii →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Honolulu
- Cindy PauHonolulu$8.2M
- Alan ParsaHonolulu$4.1M
- Kelsey Shikuma LeeHonolulu$19K
- Lisa WongHonolulu$12K
- Eric LeeHonolulu$3K
- Isabel CasimiroHonolulu$2K
- Se Mo SuhHonolulu$2K
- Chanhaeng RheeHonolulu$2K
- Kamonkiat WirunsawanyaHonolulu$1K
- Jennifer LohHonolulu$890
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.